<code id='6C25F84E0A'></code><style id='6C25F84E0A'></style>
    • <acronym id='6C25F84E0A'></acronym>
      <center id='6C25F84E0A'><center id='6C25F84E0A'><tfoot id='6C25F84E0A'></tfoot></center><abbr id='6C25F84E0A'><dir id='6C25F84E0A'><tfoot id='6C25F84E0A'></tfoot><noframes id='6C25F84E0A'>

    • <optgroup id='6C25F84E0A'><strike id='6C25F84E0A'><sup id='6C25F84E0A'></sup></strike><code id='6C25F84E0A'></code></optgroup>
        1. <b id='6C25F84E0A'><label id='6C25F84E0A'><select id='6C25F84E0A'><dt id='6C25F84E0A'><span id='6C25F84E0A'></span></dt></select></label></b><u id='6C25F84E0A'></u>
          <i id='6C25F84E0A'><strike id='6C25F84E0A'><tt id='6C25F84E0A'><pre id='6C25F84E0A'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:focus    Page View:79755
          Calling Bullshit course University of Washington
          Screenshot via callingbullshit.org

          Tired of alternative facts, fake news, and breathless hyperbole, two professors at the University of Washington are trying to strike a blow for science.

          Their weapon? A new course: “Calling Bullshit In the Age of Big Data.”

          advertisement

          The class website and colorful syllabus went online last month and almost instantly went viral.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          explore

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          This gene therapy has record $4.25 million price. It's saved children.
          This gene therapy has record $4.25 million price. It's saved children.

          AdobeEverymorning,VictoriaRasberrygetsupbefore6a.m.,walkstothebedroomdownthehall,andhelpsher8-year-o

          read more
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more

          BridgeBio heart drug succeeds in pivotal study

          AdobeAdrugdevelopedbythebiotechfirmBridgeBiototreatanincreasinglycommonheartconditionsucceededinitsm